PMID: 11342800May 9, 2001Paper

Uric acid and cardiovascular disease: a renal-cardiac relationship?

Current Opinion in Nephrology and Hypertension
B F Culleton

Abstract

Elevated serum uric acid is a frequent finding in patients with kidney disease and cardiovascular disease. Intrarenal ischaemia, induced by hypertension, increased sympathetic nervous system activity, and hyperinsulinaemia have all been implicated in reduced renal clearance of urate. This frequently results in elevated serum uric acid levels. The association of hyperuricaemia with cardiovascular disease remains controversial. Current evidence suggests that serum uric acid may provide additional prognostic information in patients with essential hypertension. However, there has been no test of the hypothesis that a reduction in serum uric acid would prevent cardiovascular disease. Furthermore, a critical review of the current literature does not support a causal role of serum uric acid in the development of cardiovascular disease. Serum uric acid probably reflects and integrates different risk factors and their possible interactions.

References

Nov 1, 1977·The Journal of Clinical Investigation·M H GinsbergD J McCarty
Apr 1, 1975·Pediatric Research·O D Saugstad
Mar 1, 1992·Obstetrics and Gynecology·K B PorterR Benoit
Jul 1, 1989·Journal of Molecular and Cellular Cardiology·T HuizerR Troquay
Aug 1, 1986·Kidney International·L H Beck
Jan 1, 1985·American Journal of Epidemiology·F N BrandW P Castelli
Sep 1, 1972·Kidney International·E W HolmesJ B Wyngaarden
Sep 1, 1966·The New England Journal of Medicine·P J CannonJ H Laragh
Nov 1, 1993·European Journal of Pediatrics·Y HayabuchiY Kuroda
Jan 1, 1996·American Journal of Obstetrics and Gynecology·A ManyJ M Roberts
Aug 1, 1997·Heart·S G WannametheeP H Whincup
Mar 20, 1998·Stroke; a Journal of Cerebral Circulation·S LehtoM Laakso
Feb 19, 1999·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·R J JohnsonA B Fogo
Jul 3, 1999·Annals of Internal Medicine·B F CulletonD Levy
Jul 27, 1999·Journal of Hypertension·J G Puig, L M Ruilope
Dec 1, 1960·Medicine·J H TALBOTT, K L TERPLAN
Jun 1, 1951·Annals of Internal Medicine·M M GERTLERS A LEVINE
Feb 9, 1889·British Medical Journal·A Haig

❮ Previous
Next ❯

Citations

Dec 5, 2013·European Journal of Human Genetics : EJHG·V Saroja VorugantiShelley A Cole
Dec 19, 2003·Advances in Renal Replacement Therapy·Raymond Camille VanholderPeter Paul De Deyn
Aug 21, 2002·Current Opinion in Nephrology and Hypertension·Domenic A Sica, Anton C Schoolwerth
Jul 18, 2012·BMC Cardiovascular Disorders·José Alexandre Addeo CipolliWilson Nadruz Junior
Oct 18, 2011·Seminars in Nephrology·Richard J JohnsonLaura Gabriela Sánchez-Lozada
Aug 3, 2010·Journal of the Neurological Sciences·Sung Hyuk Heo, Seung-Hoon Lee
Oct 1, 2008·Clinica Chimica Acta; International Journal of Clinical Chemistry·Won Cheoul JangSeong-Kyu Kim
Mar 20, 2008·Clinica Chimica Acta; International Journal of Clinical Chemistry·Giuseppe LippiGiovanni Targher
Oct 27, 2006·European Journal of Heart Failure·Domingo A Pascual-FigalMariano Valdes
Oct 22, 2015·Hipertensión y riesgo vascular·K U KunikullayaR Chinnaswamy
Sep 5, 2009·Journal of the American Society of Nephrology : JASN·Orson W Moe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.